RCM
TPI

Rotella Capital Management’s TIANYIN PHARMACEUTICAL TPI Stock Holding History

Rotella Capital Management’s Portfolio TPI Stock Details TPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-30,305
Closed -$30K – 445
2014
Q1 		$30K Buy
+30,305
New +$30.4K 0.04% 214

Other funds holding TPI

PAM
Pope Asset Management Memphis, Tennessee $162M AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RIM
Regent Investment Management Louisville, Kentucky $373M AUM 10.22% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BWFA
Baltimore-Washington Financial Advisors Columbia, Maryland $2.32B AUM 16.8% 1-Year Est. Return

Rotella Capital Management's TPI Position: Q2 2014 in Review

Rotella Capital Management sold out of TIANYIN PHARMACEUTICAL (TPI) in Q2 2014, closing a stake of 30,305 shares — an estimated $30K sold.

Rotella Capital Management first reported a position in TPI in Q1 2014 and held it in 1 quarter. The position peaked at $30K in Q1 2014. 6 funds tracked by Wall St. Rank hold TPI as of Q2 2014.

  • Rotella Capital Management reported no remaining TIANYIN PHARMACEUTICAL position as of Q2 2014 after selling out during the quarter.
  • Rotella Capital Management sold 30,305 TIANYIN PHARMACEUTICAL shares in Q2 2014, an estimated $30K.
  • Rotella Capital Management first reported a position in TIANYIN PHARMACEUTICAL in Q1 2014 and held it in 1 quarter.
  • Rotella Capital Management's TIANYIN PHARMACEUTICAL position peaked at $30K in Q1 2014.
  • 6 funds tracked by Wall St. Rank held TIANYIN PHARMACEUTICAL as of Q2 2014.

Based on Rotella Capital Management's 13F filing for Q2 2014, filed 18 Aug 2014.